Feedback / Questions
N-acetylcysteine amide (NPI 001) - Nacuity Pharma
https://www.globenewswire.com/news-release/2025/01/21/3012724/0/en/Nacuity-Pharmaceuticals-Granted-U-S-FDA-Fast-Track-Designation-for-NPI-001-N-acetylcysteine-amide-Tablets-for-the-Treatment-of-Retinitis-Pigmentosa.html
Jan 21, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next